Skip to main content
OpenTrials
Completed

NCT Number: NCT00939354

Asthma in the Elderly: The Role of Exhaled Nitric Oxide Measurements

This study will investigate the importance of exhaled nitric oxide measurements in subjects with asthma age 65 and older. This group of patients has been ignored in most previous asthma studies.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subjects with asthma over the age of 65 followed in our practice, non-smokers and able to give informed consent to participate in the study

Exclusion criteria

  • Smokers, subjects of diminished mental capacity

Treatment and study plan

Primary outcomes

  1. Exhaled Nitric Oxide (FENO) levels and their changes with time

    Time frame: One year

Secondary outcomes

  1. Correlations of FENO with subjects' demographics, comorbidities, treatment, symptoms, or spiromentric values

    Time frame: One year

Sponsors and collaborators

Lead sponsor

Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C.

Other

Registry information

Important dates

Study start
2009
Primary completion
2011
Study completion
2011
First posted
Jul 15, 2009
Registry last updated
Oct 29, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.